Please note that we have stopped the regular imports of Gene Expression Omnibus (GEO) data into ArrayExpress. This may not be the latest version of this experiment.

E-GEOD-26537 - Heparins treated human breast cancer MCF-7 cell

Status
Released on 11 January 2011, last updated on 11 August 2015
Organism
Homo sapiens
Samples (12)
Array (1)
Protocols (8)
Description
To inquire the a possible mechanism for heparin treatment improved cancer survival, three type of heparins: one standard heparin (unfractionated heparin (UFH), and two of low molecular weight heparin (LMWH) Fragmin and Clexane were used to treat cell for 24 hours. Total RNA was used for cDNA Microarray assay. Untreated cells were used as controls. Cell were treated by three type of heparins one standard heparin (unfractionated heparin (UFH), and two of low molecular weight heparin (LMWH) Fragmin and Clexane (40 IU/ml for each) were used to treat cell for 24 hours. Triplicate samples were prepared.
Experiment type
transcription profiling by array 
Contact
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-GEOD-26537.idf.txt
Sample and data relationshipE-GEOD-26537.sdrf.txt
Raw data (1)E-GEOD-26537.raw.1.zip
Processed data (1)E-GEOD-26537.processed.1.zip
Array designA-AGIL-28.adf.txt
Links